TreeWAS – Variant ID: rs11241696

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C15.9 Oesophagus, unspecified	0.000	0.931	0.069
C15.5 Lower third of oesophagus	0.000	0.939	0.061
C15 Malignant neoplasm of oesophagus	0.000	0.939	0.061
Q61.3 Polycystic kidney, unspecified	0.000	0.940	0.060
Q61 Cystic kidney disease	0.000	0.942	0.058
Q61.2 Polycystic kidney, adult type	0.000	0.943	0.057
Q61.9 Cystic kidney disease, unspecified	0.000	0.953	0.047
Q61.5 Medullary cystic kidney	0.000	0.953	0.046
C15.3 Upper third of oesophagus	0.000	0.956	0.044
C15.8 Overlapping lesion of oesophagus	0.000	0.956	0.044
C15.2 Abdominal part of oesophagus	0.000	0.956	0.044
C15.1 Thoracic part of oesophagus	0.000	0.956	0.044
C15.0 Cervical part of oesophagus	0.000	0.956	0.044
Q61.0 Congenital single renal cyst	0.000	0.957	0.043
Q61.8 Other cystic kidney diseases	0.000	0.958	0.042
Q61.4 Renal dysplasia	0.000	0.958	0.042
Q61.1 Polycystic kidney, infantile type	0.000	0.958	0.042
C15.4 Middle third of oesophagus	0.000	0.961	0.039
Q60-Q64 Congenital malformations of the urinary system	0.000	0.980	0.019
R39.1 Other difficulties with micturition	0.000	0.981	0.019
D69.6 Thrombocytopenia, unspecified	0.000	0.981	0.019
Q63 Other congenital malformations of kidney	0.000	0.984	0.016
D69 Purpura and other haemorrhagic conditions	0.000	0.985	0.015
D69.5 Secondary thrombocytopenia	0.000	0.986	0.014
D86.8 Sarcoidosis of other and combined sites	0.014	0.986	0.000
Q63.1 Lobulated, fused and horseshoe kidney	0.000	0.986	0.014
Q64 Other congenital malformations of urinary system	0.000	0.986	0.013
Q62 Congenital obstructive defects of renal pelvis and congenital malformations of ureter	0.000	0.987	0.013
N41.9 Inflammatory disease of prostate, unspecified	0.013	0.987	0.000
C22.0 Liver cell carcinoma	0.000	0.988	0.012
Q60 Renal agenesis and other reduction defects of kidney	0.001	0.988	0.011
D80.1 Nonfamilial hypogammaglobulinaemia	0.012	0.988	0.000
R00.2 Palpitations	0.012	0.988	0.000
Q63.9 Congenital malformation of kidney, unspecified	0.000	0.988	0.011
Q63.8 Other specified congenital malformations of kidney	0.000	0.988	0.011
Q63.3 Hyperplastic and giant kidney	0.000	0.988	0.011
D69.0 Allergic purpura	0.000	0.988	0.012
D80 Immunodeficiency with predominantly antibody defects	0.012	0.988	0.000
Q63.2 Ectopic kidney	0.000	0.988	0.011
D69.8 Other specified haemorrhagic conditions	0.000	0.989	0.011
D69.2 Other nonthrombocytopenic purpura	0.000	0.989	0.011
D69.1 Qualitative platelet defects	0.000	0.989	0.011
D86 Sarcoidosis	0.011	0.989	0.000
D69.3 Idiopathic thrombocytopenic purpura	0.000	0.989	0.011
D69.9 Haemorrhagic condition, unspecified	0.000	0.989	0.011
D69.4 Other primary thrombocytopenia	0.000	0.989	0.011
D80-D89 Certain disorders involving the immune mechanism	0.011	0.989	0.000
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.000	0.989	0.011
Q64.9 Congenital malformation of urinary system, unspecified	0.000	0.990	0.010
Q64.8 Other specified congenital malformations of urinary system	0.000	0.990	0.010
Q64.7 Other congenital malformations of bladder and urethra	0.000	0.990	0.010
Q64.6 Congenital diverticulum of bladder	0.000	0.990	0.010
Q64.5 Congenital absence of bladder and urethra	0.000	0.990	0.010
Q64.4 Malformation of urachus	0.000	0.990	0.010
Q64.2 Congenital posterior urethral valves	0.000	0.990	0.010
Q64.1 Exstrophy of urinary bladder	0.000	0.990	0.010
Q64.0 Epispadias	0.000	0.990	0.010
D23.1 Skin of eyelid, including canthus	0.000	0.990	0.010
Q62.8 Other congenital malformations of ureter	0.000	0.990	0.009
Q62.7 Congenital vesico-uretero-renal reflux	0.000	0.990	0.009
Q62.6 Malposition of ureter	0.000	0.990	0.009
Q62.4 Agenesis of ureter	0.000	0.990	0.009
Q62.3 Other obstructive defects of renal pelvis and ureter	0.000	0.990	0.009
Q62.2 Congenital megaloureter	0.000	0.990	0.009
Q62.1 Atresia and stenosis of ureter	0.000	0.990	0.009
Q62.0 Congenital hydronephrosis	0.000	0.990	0.009
C22.1 Intrahepatic bile duct carcinoma	0.000	0.990	0.010
Q63.0 Accessory kidney	0.000	0.990	0.010
Q64.3 Other atresia and stenosis of urethra and bladder neck	0.000	0.990	0.009
D80.2 Selective deficiency of immunoglobulin A [IgA]	0.009	0.991	0.000
C22.9 Liver, unspecified	0.000	0.991	0.009
D80.4 Selective deficiency of immunoglobulin M [IgM]	0.009	0.991	0.000
D86.3 Sarcoidosis of skin	0.009	0.991	0.000
Q60.6 Potter's syndrome	0.001	0.991	0.008
Q60.5 Renal hypoplasia, unspecified	0.001	0.991	0.008
Q60.4 Renal hypoplasia, bilateral	0.001	0.991	0.008
Q60.3 Renal hypoplasia, unilateral	0.001	0.991	0.008
Q60.1 Renal agenesis, bilateral	0.001	0.991	0.008
D89 Other disorders involving the immune mechanism, not elsewhere classified	0.009	0.991	0.000
Q60.0 Renal agenesis, unilateral	0.000	0.991	0.008
Q62.5 Duplication of ureter	0.001	0.991	0.008
D84 Other immunodeficiencies	0.009	0.991	0.000
K14.0 Glossitis	0.000	0.991	0.009
D80.9 Immunodeficiency with predominantly antibody defects, unspecified	0.008	0.991	0.000
D80.8 Other immunodeficiencies with predominantly antibody defects	0.008	0.991	0.000
D80.7 Transient hypogammaglobulinaemia of infancy	0.008	0.991	0.000
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia	0.008	0.991	0.000
D80.5 Immunodeficiency with increased immunoglobulin M [IgM]	0.008	0.991	0.000
D80.0 Hereditary hypogammaglobulinaemia	0.008	0.991	0.000
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions	0.000	0.991	0.008
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.008	0.991	0.000
D86.1 Sarcoidosis of lymph nodes	0.008	0.992	0.000
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses	0.008	0.992	0.000
D83 Common variable immunodeficiency	0.008	0.992	0.000
Z97.8 Presence of other specified devices	0.008	0.992	0.000
D82 Immunodeficiency associated with other major defects	0.008	0.992	0.000
D81 Combined immunodeficiencies	0.008	0.992	0.000
C22.7 Other specified carcinomas of liver	0.000	0.992	0.008
C22.4 Other sarcomas of liver	0.000	0.992	0.008
C22.3 Angiosarcoma of liver	0.000	0.992	0.008
C22.2 Hepatoblastoma	0.000	0.992	0.008
D84.1 Defects in the complement system	0.008	0.992	0.000
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified	0.008	0.992	0.000
D89.9 Disorder involving the immune mechanism, unspecified	0.008	0.992	0.000
D68 Other coagulation defects	0.000	0.992	0.008
Z50.7 Occupational therapy and vocational rehabilitation, not elsewhere classified	0.000	0.993	0.007
D68.5 Primary Thrombophilia	0.000	0.993	0.007
D68.8 Other specified coagulation defects	0.000	0.993	0.007
D86.0 Sarcoidosis of lung	0.007	0.993	0.000
D89.3 Immune reconstitution syndrome	0.006	0.993	0.000
D89.1 Cryoglobulinaemia	0.006	0.993	0.000
D84.8 Other specified immunodeficiencies	0.006	0.993	0.000
D84.0 Lymphocyte function antigen-1 [LFA-1] defect	0.006	0.993	0.000
Z50.1 Other physical therapy	0.000	0.993	0.007
M79.62 Pain in limb (Upper arm)	0.006	0.994	0.000
D67 Hereditary factor IX deficiency	0.000	0.994	0.006
Q60.2 Renal agenesis, unspecified	0.001	0.994	0.006
D83.9 Common variable immunodeficiency, unspecified	0.006	0.994	0.000
R18 Ascites	0.000	0.994	0.006
D89.0 Polyclonal hypergammaglobulinaemia	0.006	0.994	0.000
D83.8 Other common variable immunodeficiencies	0.006	0.994	0.000
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells	0.006	0.994	0.000
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders	0.006	0.994	0.000
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function	0.006	0.994	0.000
D68.6 Other Thrombophilia	0.000	0.994	0.006
C15-C26 Malignant neoplasms of digestive organs	0.000	0.994	0.006
D81.9 Combined immunodeficiency, unspecified	0.006	0.994	0.000
D81.8 Other combined immunodeficiencies	0.006	0.994	0.000
D81.7 Major histocompatibility complex class II deficiency	0.006	0.994	0.000
D81.6 Major histocompatibility complex class I deficiency	0.006	0.994	0.000
D81.5 Purine nucleoside phosphorylase [PNP] deficiency	0.006	0.994	0.000
D81.4 Nezelof's syndrome	0.006	0.994	0.000
D81.3 Adenosine deaminase [ADA] deficiency	0.006	0.994	0.000
D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers	0.006	0.994	0.000
D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers	0.006	0.994	0.000
D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis	0.006	0.994	0.000
D82.9 Immunodeficiency associated with major defect, unspecified	0.006	0.994	0.000
D82.8 Immunodeficiency associated with other specified major defects	0.006	0.994	0.000
D82.4 Hyperimmunoglobulin E [IgE] syndrome	0.006	0.994	0.000
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus	0.006	0.994	0.000
D82.2 Immunodeficiency with short-limbed stature	0.006	0.994	0.000
D82.1 Di George's syndrome	0.006	0.994	0.000
D82.0 Wiskott-Aldrich syndrome	0.006	0.994	0.000
D66 Hereditary factor VIII deficiency	0.000	0.994	0.006
D65 Disseminated intravascular coagulation [defibrination syndrome]	0.000	0.994	0.006
D68.4 Acquired coagulation factor deficiency	0.000	0.994	0.006
M79.67 Pain in limb (Ankle and foot)	0.000	0.994	0.006
D68.1 Hereditary factor XI deficiency	0.000	0.994	0.005
D68.0 Von Willebrand's disease	0.000	0.994	0.005
Z08.9 Follow-up examination after unspecified treatment for malignant neoplasm	0.000	0.994	0.006
D84.9 Immunodeficiency, unspecified	0.005	0.995	0.000
Z50 Care involving use of rehabilitation procedures	0.000	0.995	0.005
D68.2 Hereditary deficiency of other clotting factors	0.000	0.995	0.005
D68.9 Coagulation defect, unspecified	0.000	0.995	0.005
N83.2 Other and unspecified ovarian cysts	0.000	0.995	0.005
D68.3 Haemorrhagic disorder due to circulating anticoagulants	0.000	0.995	0.005
Z50.9 Care involving use of rehabilitation procedure, unspecified	0.000	0.995	0.005
D86.9 Sarcoidosis, unspecified	0.005	0.995	0.000
U80.0 Penicillin resistant agent	0.005	0.995	0.000
Z50.5 Speech therapy	0.000	0.995	0.005
C26 Malignant neoplasm of other and ill-defined digestive organs	0.000	0.995	0.004
C17 Malignant neoplasm of small intestine	0.000	0.995	0.004
U80 Agent resistant to penicillin and related antibiotics	0.004	0.996	0.000
L03.3 Cellulitis of trunk	0.000	0.996	0.004
U51.0 Not Previously admitted to a psyciatric hospital	0.004	0.996	0.000
Z50.2 Alcohol rehabilitation	0.000	0.996	0.004
N92.3 Ovulation bleeding	0.000	0.996	0.004
D89.2 Hypergammaglobulinaemia, unspecified	0.004	0.996	0.000
C23 Malignant neoplasm of gallbladder	0.000	0.996	0.004
Z50.6 Orthoptic training	0.000	0.996	0.004
Z50.3 Drug rehabilitation	0.000	0.996	0.004
L53.9 Erythematous condition, unspecified	0.004	0.996	0.000
U80.1 Methicillin resistant agent	0.004	0.996	0.000
C16 Malignant neoplasm of stomach	0.000	0.996	0.004
U80.8 Agent resistant to other penicillin-related antibiotic	0.004	0.996	0.000
C17.0 Duodenum	0.000	0.996	0.004
C21 Malignant neoplasm of anus and anal canal	0.000	0.996	0.004
C26.0 Intestinal tract, part unspecified	0.000	0.996	0.004
C17.2 Ileum	0.000	0.996	0.004
U51 Admission status on psychiatric patients	0.004	0.996	0.000
N83.9 Noninflammatory disorder of ovary, Fallopian tube and broad ligament, unspecified	0.000	0.996	0.004
C16.5 Lesser curvature of stomach, unspecified	0.000	0.996	0.004
D41.4 Bladder	0.000	0.996	0.004
R87.6 Abnormal cytological findings	0.004	0.996	0.000
C21.1 Anal canal	0.000	0.996	0.003
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.003	0.996	0.000
C17.8 Overlapping lesion of small intestine	0.000	0.996	0.003
C17.3 Meckel's diverticulum	0.000	0.996	0.003
C26.8 Overlapping lesion of digestive system	0.000	0.996	0.003
C26.1 Spleen	0.000	0.996	0.003
C92.1 Chronic myeloid leukaemia	0.003	0.996	0.000
N64.9 Disorder of breast, unspecified	0.003	0.997	0.000
C17.1 Jejunum	0.000	0.997	0.003
U89.8 Agent resistant to other single specified antibiotic	0.003	0.997	0.000
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.000	0.997	0.003
K62.9 Disease of anus and rectum, unspecified	0.000	0.997	0.003
C16.6 Greater curvature of stomach, unspecified	0.000	0.997	0.003
L98.8 Other specified disorders of skin and subcutaneous tissue	0.000	0.997	0.003
I77.9 Disorder of arteries and arterioles, unspecified	0.003	0.997	0.000
M20.2 Hallux rigidus	0.000	0.997	0.003
R45.8 Other symptoms and signs involving emotional state	0.000	0.997	0.003
R00.0 Tachycardia, unspecified	0.003	0.997	0.000
R87.9 Unspecified abnormal finding	0.003	0.997	0.000
N64.5 Other signs and symptoms in breast	0.003	0.997	0.000
C25 Malignant neoplasm of pancreas	0.000	0.997	0.003
C16.8 Overlapping lesion of stomach	0.000	0.997	0.003
C16.4 Pylorus	0.000	0.997	0.003
C16.1 Fundus of stomach	0.000	0.997	0.003
C26.9 Ill-defined sites within the digestive system	0.000	0.997	0.003
R00 Abnormalities of heart beat	0.003	0.997	0.000
C21.2 Cloacogenic zone	0.000	0.997	0.003
F60.9 Personality disorder, unspecified	0.003	0.997	0.000
R39 Other symptoms and signs involving the urinary system	0.000	0.997	0.003
C92.7 Other myeloid leukaemia	0.003	0.997	0.000
C92 Myeloid leukaemia	0.003	0.997	0.000
C25.0 Head of pancreas	0.000	0.997	0.003
C19 Malignant neoplasm of rectosigmoid junction	0.000	0.997	0.003
U51.2 Previously admitted to a psychiatric hospital of another provider	0.003	0.997	0.000
C24.9 Biliary tract, unspecified	0.000	0.997	0.003
N83 Noninflammatory disorders of ovary, Fallopian tube and broad ligament	0.000	0.997	0.003
R87 Abnormal findings in specimens from female genital organs	0.003	0.997	0.000
I62.9 Intracranial haemorrhage (nontraumatic), unspecified	0.000	0.997	0.003
M46.99 Inflammatory spondylopathy, unspecified (Site unspecified)	0.003	0.997	0.000
M46.90 Inflammatory spondylopathy, unspecified (Multiple sites in spine)	0.003	0.997	0.000
U50 Level of care administered to neonates	0.003	0.997	0.000
U07 Emergency use of U07	0.003	0.997	0.000
U06 Emergency use of U06	0.003	0.997	0.000
U04 Severe acute respiratory syndrome [SARS]	0.003	0.997	0.000
U52 First in a series of a regular day/night admissions	0.003	0.997	0.000
C79.7 Secondary malignant neoplasm of adrenal gland	0.000	0.997	0.003
N64.4 Mastodynia	0.003	0.997	0.000
C16.2 Body of stomach	0.000	0.997	0.003
C16.3 Pyloric antrum	0.000	0.997	0.003
N64 Other disorders of breast	0.003	0.997	0.000
C24.8 Overlapping lesion of biliary tract	0.000	0.997	0.002
M46.9 Inflammatory spondylopathy, unspecified	0.003	0.997	0.000
N83.3 Acquired atrophy of ovary and Fallopian tube	0.000	0.997	0.003
Y83.3 Surgical operation with formation of external stoma	0.003	0.997	0.000
U89 Agent resistant to other and unspecified antibiotics	0.003	0.997	0.000
M43.02 Spondylolysis (Cervical region)	0.000	0.997	0.003
C16.0 Cardia	0.000	0.997	0.003
M46.96 Inflammatory spondylopathy, unspecified (Lumbar region)	0.003	0.997	0.000
C92.4 Acute promyelocytic leukaemia	0.003	0.997	0.000
C92.0 Acute myeloid leukaemia	0.003	0.997	0.000
C85.1 B-cell lymphoma, unspecified	0.003	0.997	0.000
N64.3 Galactorrhoea not associated with childbirth	0.002	0.997	0.000
C17.9 Small intestine, unspecified	0.000	0.997	0.002
C25.2 Tail of pancreas	0.000	0.997	0.002
C25.8 Overlapping lesion of pancreas	0.000	0.997	0.002
C25.4 Endocrine pancreas	0.000	0.997	0.002
C16.9 Stomach, unspecified	0.000	0.997	0.002
C21.8 Overlapping lesion of rectum, anus and anal canal	0.001	0.998	0.002
L98.9 Disorder of skin and subcutaneous tissue, unspecified	0.000	0.998	0.002
Z50.4 Psychotherapy, not elsewhere classified	0.000	0.998	0.002
U81 Agent resistant to vancomycin and related antibiotics	0.002	0.998	0.000
C25.3 Pancreatic duct	0.000	0.998	0.002
R39.2 Extrarenal uraemia	0.000	0.998	0.002
C92.9 Myeloid leukaemia, unspecified	0.002	0.998	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.002	0.998	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.002	0.998	0.000
C92.5 Acute myelomonocytic leukaemia	0.002	0.998	0.000
C92.3 Myeloid sarcoma	0.002	0.998	0.000
C92.2 Subacute myeloid leukaemia	0.002	0.998	0.000
F60 Specific personality disorders	0.002	0.998	0.000
F60.8 Other specific personality disorders	0.002	0.998	0.000
M46.98 Inflammatory spondylopathy, unspecified (Sacral and sacrococcygeal region)	0.002	0.998	0.000
N83.7 Haematoma of broad ligament	0.000	0.998	0.002
N83.6 Haematosalpinx	0.000	0.998	0.002
N83.4 Prolapse and hernia of ovary and Fallopian tube	0.000	0.998	0.002
R87.8 Other abnormal findings	0.002	0.998	0.000
R87.5 Abnormal microbiological findings	0.002	0.998	0.000
R87.4 Abnormal immunological findings	0.002	0.998	0.000
R87.3 Abnormal level of substances chiefly nonmedicinal as to source	0.002	0.998	0.000
R87.2 Abnormal level of other drugs, medicaments and biological substances	0.002	0.998	0.000
R87.1 Abnormal level of hormones	0.002	0.998	0.000
R87.0 Abnormal level of enzymes	0.002	0.998	0.000
N83.8 Other noninflammatory disorders of ovary, Fallopian tube and broad ligament	0.000	0.998	0.002
N83.5 Torsion of ovary, ovarian pedicle and Fallopian tube	0.000	0.998	0.002
J95.8 Other postprocedural respiratory disorders	0.002	0.998	0.000
U04.9 Severe acute respiratory syndrome [SARS], unspecified	0.002	0.998	0.000
U06.9 Emergency use of U06.9	0.002	0.998	0.000
U06.8 Emergency use of U06.8	0.002	0.998	0.000
U06.7 Emergency use of U06.7	0.002	0.998	0.000
U06.6 Emergency use of U06.6	0.002	0.998	0.000
U06.5 Emergency use of U06.5	0.002	0.998	0.000
U06.4 Emergency use of U06.4	0.002	0.998	0.000
U06.3 Emergency use of U06.3	0.002	0.998	0.000
U06.2 Emergency use of U06.2	0.002	0.998	0.000
U06.1 Emergency use of U06.1	0.002	0.998	0.000
U06.0 Emergency use of U06.0	0.002	0.998	0.000
U07.9 Emergency use of U07.9	0.002	0.998	0.000
U07.8 Emergency use of U07.8	0.002	0.998	0.000
U07.7 Emergency use of U07.7	0.002	0.998	0.000
U07.6 Emergency use of U07.6	0.002	0.998	0.000
U07.5 Emergency use of U07.5	0.002	0.998	0.000
U07.4 Emergency use of U07.4	0.002	0.998	0.000
U07.3 Emergency use of U07.3	0.002	0.998	0.000
U07.2 Emergency use of U07.2	0.002	0.998	0.000
U07.1 Emergency use of U07.1	0.002	0.998	0.000
U07.0 Emergency use of U07.0	0.002	0.998	0.000
U50.9 Inquest Adjourned Death	0.002	0.998	0.000
U50.3 Level of care administered to neonates (Maximal Intensive Care)	0.002	0.998	0.000
U50.2 Level of care administered to neonates (High Dependancy Intensive Care)	0.002	0.998	0.000
U50.1 Level of care administered to neonates (Special Care)	0.002	0.998	0.000
U50.0 Level of care administered to neonates (Normal Care)	0.002	0.998	0.000
U51.1 Previously admitted to a psychiatric hospital of the provider	0.002	0.998	0.000
B44.1 Other pulmonary aspergillosis	0.002	0.998	0.000
N64.2 Atrophy of breast	0.002	0.998	0.000
N64.0 Fissure and fistula of nipple	0.002	0.998	0.000
R39.0 Extravasation of urine	0.000	0.998	0.002
M46.95 Inflammatory spondylopathy, unspecified (Thoracolumbar region)	0.002	0.998	0.000
M46.94 Inflammatory spondylopathy, unspecified (Thoracic region)	0.002	0.998	0.000
M46.93 Inflammatory spondylopathy, unspecified (Cervicothoracic region)	0.002	0.998	0.000
M46.91 Inflammatory spondylopathy, unspecified (Occipito-atlanto-axial region)	0.002	0.998	0.000
D61.9 Aplastic anaemia, unspecified	0.000	0.998	0.002
C25.7 Other parts of pancreas	0.000	0.998	0.002
U89.9 Agent resistant to unspecified antibiotic	0.002	0.998	0.000
R87.7 Abnormal histological findings	0.002	0.998	0.000
L98 Other disorders of skin and subcutaneous tissue, not elsewhere classified	0.000	0.998	0.002
M46.97 Inflammatory spondylopathy, unspecified (Lumbosacral region)	0.002	0.998	0.000
Q07.0 Arnold-Chiari syndrome	0.002	0.998	0.000
C24.1 Ampulla of Vater	0.000	0.998	0.002
C24.0 Extrahepatic bile duct	0.000	0.998	0.002
F60.7 Dependent personality disorder	0.002	0.998	0.000
Q39.6 Diverticulum of oesophagus	0.002	0.998	0.000
C62.9 Testis, unspecified	0.000	0.998	0.002
E87.1 Hypo-osmolality and hyponatraemia	0.000	0.998	0.002
F60.0 Paranoid personality disorder	0.002	0.998	0.000
F60.6 Anxious [avoidant] personality disorder	0.002	0.998	0.000
N85.2 Hypertrophy of uterus	0.000	0.998	0.002
U82-U85 Resistance to antimicrobial and antineoplastic drugs	0.002	0.998	0.000
C25.1 Body of pancreas	0.000	0.998	0.002
U81.8 Agent resistant to other vancomycin-related antibiotic	0.002	0.998	0.000
M46.92 Inflammatory spondylopathy, unspecified (Cervical region)	0.002	0.998	0.000
R47.0 Dysphasia and aphasia	0.002	0.998	0.000
Z50.0 Cardiac rehabilitation	0.000	0.998	0.002
Chapter XXII Codes for special purposes	0.002	0.998	0.000
C21.0 Anus, unspecified	0.001	0.998	0.001
F60.4 Histrionic personality disorder	0.002	0.998	0.000
F60.2 Dissocial personality disorder	0.002	0.998	0.000
F60.1 Schizoid personality disorder	0.002	0.998	0.000
L30.8 Other specified dermatitis	0.002	0.998	0.000
Q23.1 Congenital insufficiency of aortic valve	0.002	0.998	0.000
K05.3 Chronic periodontitis	0.002	0.998	0.000
M43.06 Spondylolysis (Lumbar region)	0.000	0.998	0.002
E87.0 Hyperosmolality and hypernatraemia	0.000	0.998	0.002
M43.0 Spondylolysis	0.000	0.998	0.002
D03.7 Melanoma in situ of lower limb, including hip	0.000	0.998	0.002
E87.5 Hyperkalaemia	0.000	0.998	0.002
K11.2 Sialoadenitis	0.000	0.998	0.002
N64.1 Fat necrosis of breast	0.002	0.998	0.000
N93.9 Abnormal uterine and vaginal bleeding, unspecified	0.002	0.998	0.000
Z50.8 Care involving use of rehabilitation procedures	0.000	0.998	0.002
L53 Other erythematous conditions	0.002	0.998	0.000
G91.9 Hydrocephalus, unspecified	0.002	0.998	0.000
K63.3 Ulcer of intestine	0.000	0.998	0.002
Q44.6 Cystic disease of liver	0.000	0.998	0.002
Q23 Congenital malformations of aortic and mitral valves	0.002	0.998	0.000
L98.7 Excessive and redundant skin and subcutaneous tissue	0.000	0.998	0.002
L98.6 Other infiltrative disorders of skin and subcutaneous tissue	0.000	0.998	0.002
L98.3 Eosinophilic cellulitis [Wells]	0.000	0.998	0.002
L98.2 Febrile neutrophilic dermatosis [Sweet]	0.000	0.998	0.002
F60.5 Anankastic personality disorder	0.002	0.998	0.000
I12.0 Hypertensive renal disease with renal failure	0.000	0.998	0.002
L98.5 Mucinosis of skin	0.000	0.998	0.002
G91.2 Normal-pressure hydrocephalus	0.002	0.998	0.000
G95.9 Disease of spinal cord, unspecified	0.002	0.998	0.000
Q23.0 Congenital stenosis of aortic valve	0.002	0.998	0.000
F60.3 Emotionally unstable personality disorder	0.002	0.998	0.000
K46.9 Unspecified abdominal hernia without obstruction or gangrene	0.000	0.998	0.002
L98.1 Factitial dermatitis	0.000	0.998	0.002
U84 Resistance to other antimicrobial drugs	0.002	0.998	0.000
U83 Resistance to other antibiotics	0.002	0.998	0.000
U82 Resistance to betalactam antibiotics	0.002	0.998	0.000
U85 Resistance to antineoplastic drugs	0.002	0.998	0.000
D03.5 Melanoma in situ of trunk	0.000	0.998	0.002
F30.0 Hypomania	0.002	0.998	0.000
Q07 Other congenital malformations of nervous system	0.002	0.998	0.000
G91.8 Other hydrocephalus	0.002	0.998	0.000
Q39 Congenital malformations of oesophagus	0.002	0.998	0.000
E61.1 Iron deficiency	0.002	0.998	0.000
L98.4 Chronic ulcer of skin, not elsewhere classified	0.000	0.998	0.002
L53.0 Toxic erythema	0.002	0.998	0.000
U81.0 Vancomycin resistant agent	0.001	0.998	0.000
G91 Hydrocephalus	0.002	0.998	0.000
C91.9 Lymphoid leukaemia, unspecified	0.002	0.998	0.000
N34.2 Other urethritis	0.000	0.998	0.002
T31.0 Burns involving less than 10% of body surface	0.000	0.998	0.002
M23.33 Other meniscus derangements (Medial collateral ligament or Other and unspecified medial meniscus)	0.002	0.998	0.000
M43.08 Spondylolysis (Sacral and sacrococcygeal region)	0.000	0.998	0.001
M43.07 Spondylolysis (Lumbosacral region)	0.000	0.998	0.001
M43.05 Spondylolysis (Thoracolumbar region)	0.000	0.998	0.001
M43.04 Spondylolysis (Thoracic region)	0.000	0.998	0.001
M43.03 Spondylolysis (Cervicothoracic region)	0.000	0.998	0.001
M43.01 Spondylolysis (Occipito-atlanto-axial region)	0.000	0.998	0.001
M43.00 Spondylolysis (Multiple sites in spine)	0.000	0.998	0.001
C91.0 Acute lymphoblastic leukaemia	0.002	0.998	0.000
D03.6 Melanoma in situ of upper limb, including shoulder	0.000	0.998	0.002
L53.3 Other chronic figurate erythema	0.001	0.998	0.000
L53.2 Erythema marginatum	0.001	0.998	0.000
L53.1 Erythema annulare centrifugum	0.001	0.998	0.000
Q21 Congenital malformations of cardiac septa	0.002	0.998	0.000
D04.4 Skin of scalp and neck	0.000	0.998	0.002
M43.09 Spondylolysis (Site unspecified)	0.000	0.998	0.001
Q23.9 Congenital malformation of aortic and mitral valves, unspecified	0.001	0.998	0.000
Q23.8 Other congenital malformations of aortic and mitral valves	0.001	0.998	0.000
Q23.4 Hypoplastic left heart syndrome	0.001	0.998	0.000
Q23.3 Congenital mitral insufficiency	0.001	0.998	0.000
Q23.2 Congenital mitral stenosis	0.001	0.998	0.000
W55.0 Home	0.002	0.998	0.000
Q20-Q28 Congenital malformations of the circulatory system	0.002	0.998	0.000
Q25.1 Coarctation of aorta	0.001	0.998	0.000
Q25 Congenital malformations of great arteries	0.001	0.998	0.000
D56.3 Thalassaemia trait	0.001	0.998	0.000
Q21.1 Atrial septal defect	0.002	0.998	0.000
D73.0 Hyposplenism	0.000	0.998	0.002
Q21.0 Ventricular septal defect	0.001	0.998	0.000
Q66.8 Other congenital deformities of feet	0.001	0.998	0.000
R47.1 Dysarthria and anarthria	0.002	0.998	0.000
U82.9 Resistance to betalactam antibiotics, unspecified	0.001	0.998	0.000
U82.8 Resistance to other betalactam antibiotics	0.001	0.998	0.000
U82.2 Extended spectrum betalactamase (ESBL) resistance	0.001	0.998	0.000
U82.1 Resistance to methicillin	0.001	0.998	0.000
U82.0 Resistance to penicillin	0.001	0.998	0.000
U83.9 Resistance to unspecified antibiotic	0.001	0.998	0.000
U83.8 Resistance to other single specified antibiotic	0.001	0.998	0.000
U83.7 Resistance to multiple antibiotics	0.001	0.998	0.000
U83.2 Resistance to quinolones	0.001	0.998	0.000
U83.1 Resistance to other vancomycin related antibiotics	0.001	0.998	0.000
U83.0 Resistance to vancomycin	0.001	0.998	0.000
U84.9 Resistance to unspecified antimicrobial drugs	0.001	0.998	0.000
U84.8 Resistance to other specified antimicrobial drug	0.001	0.998	0.000
U84.7 Resistance to multiple antimicrobial drugs	0.001	0.998	0.000
U84.3 Resistance to tuberculostatic drug(s)	0.001	0.998	0.000
U84.2 Resistance to antiviral drug(s)	0.001	0.998	0.000
U84.1 Resistance to antifungal drug(s)	0.001	0.998	0.000
U84.0 Resistance to antiparasitic drug(s)	0.001	0.998	0.000
D03 Melanoma in situ	0.000	0.998	0.002
C09.9 Tonsil, unspecified	0.000	0.998	0.002
Q07.9 Congenital malformation of nervous system, unspecified	0.001	0.998	0.000
Q07.8 Other specified congenital malformations of nervous system	0.001	0.998	0.000
R45.1 Restlessness and agitation	0.000	0.998	0.002
A87.9 Viral meningitis, unspecified	0.001	0.998	0.000
D48.6 Breast	0.001	0.998	0.000
G91.1 Obstructive hydrocephalus	0.001	0.998	0.000
H65.3 Chronic mucoid otitis media	0.002	0.998	0.000
L98.0 Pyogenic granuloma	0.000	0.998	0.001
Q39.9 Congenital malformation of oesophagus, unspecified	0.001	0.998	0.000
Q39.8 Other congenital malformations of oesophagus	0.001	0.998	0.000
Q39.5 Congenital dilatation of oesophagus	0.001	0.998	0.000
Q39.3 Congenital stenosis and stricture of oesophagus	0.001	0.998	0.000
Q39.2 Congenital tracheooesophageal fistula without atresia	0.001	0.998	0.000
Q39.1 Atresia of oesophagus with tracheooesophageal fistula	0.001	0.998	0.000
Q39.0 Atresia of oesophagus without fistula	0.001	0.998	0.000
G91.3 Posttraumatic hydrocephalus, unspecified	0.001	0.998	0.000
Q39.4 Oesophageal web	0.001	0.998	0.000
Q66.7 Pes cavus	0.001	0.998	0.000
Q44 Congenital malformations of gallbladder, bile ducts and liver	0.001	0.998	0.001
Q66 Congenital deformities of feet	0.001	0.998	0.000
G31.9 Degenerative disease of nervous system, unspecified	0.001	0.999	0.000
Q25.4 Other congenital malformations of aorta	0.001	0.999	0.000
G91.0 Communicating hydrocephalus	0.001	0.999	0.000
R45.2 Unhappiness	0.000	0.999	0.001
M46 Other inflammatory spondylopathies	0.001	0.999	0.000
N41 Inflammatory diseases of prostate	0.001	0.999	0.000
C91.4 Hairy-cell leukaemia	0.000	0.999	0.001
C91.1 Chronic lymphocytic leukaemia	0.001	0.999	0.000
D04.6 Skin of upper limb, including shoulder	0.000	0.999	0.001
I15.1 Hypertension secondary to other renal disorders	0.000	0.999	0.001
Q21.9 Congenital malformation of cardiac septum, unspecified	0.001	0.999	0.000
Q21.8 Other congenital malformations of cardiac septa	0.001	0.999	0.000
Q21.4 Aortopulmonary septal defect	0.001	0.999	0.000
Q21.3 Tetralogy of Fallot	0.001	0.999	0.000
Q21.2 Atrioventricular septal defect	0.001	0.999	0.000
Z59.0 Homelessness	0.001	0.999	0.000
R45 Symptoms and signs involving emotional state	0.000	0.999	0.001
F52.2 Failure of genital response	0.000	0.999	0.001
L23.1 Allergic contact dermatitis due to adhesives	0.001	0.999	0.000
L53.8 Other specified erythematous conditions	0.001	0.999	0.000
E87 Other disorders of fluid, electrolyte and acid-base balance	0.000	0.999	0.001
Q65-Q79 Congenital malformations and deformations of the musculoskeletal system	0.001	0.999	0.000
Q38-Q45 Other congenital malformations of the digestive system	0.001	0.999	0.000
Q00-Q07 Congenital malformations of the nervous system	0.001	0.999	0.000
C25.9 Pancreas, unspecified	0.000	0.999	0.001
F64.0 Transsexualism	0.001	0.999	0.000
Q25.9 Congenital malformation of great arteries, unspecified	0.001	0.999	0.000
Q25.8 Other congenital malformations of great arteries	0.001	0.999	0.000
Q25.7 Other congenital malformations of pulmonary artery	0.001	0.999	0.000
Q25.6 Stenosis of pulmonary artery	0.001	0.999	0.000
Q25.5 Atresia of pulmonary artery	0.001	0.999	0.000
Q25.3 Stenosis of aorta	0.001	0.999	0.000
Q25.2 Atresia of aorta	0.001	0.999	0.000
Q79.0 Congenital diaphragmatic hernia	0.001	0.999	0.000
Q26 Congenital malformations of great veins	0.001	0.999	0.000
Q22 Congenital malformations of pulmonary and tricuspid valves	0.001	0.999	0.000
Q20 Congenital malformations of cardiac chambers and connexions	0.001	0.999	0.000
H81.0 Meniere's disease	0.001	0.999	0.000
W50.9 Unspecified place	0.001	0.999	0.000
D03.9 Melanoma in situ, unspecified	0.000	0.999	0.001
D03.8 Melanoma in situ of other sites	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations